Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Last updated: March 13, 2025
Sponsor: Imperial College London
Overall Status: Active - Recruiting

Phase

N/A

Condition

Aspergillosis

Treatment

N/A

Clinical Study ID

NCT06885905
23IC8471
  • Ages > 18
  • All Genders

Study Summary

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. All patients >/= 18 years old and able to provide informed consent

  2. Patients with a diagnosis of chronic pulmonary aspergillosis

  3. To speak and understand English

  4. Able to provide informed consent

Study Design

Total Participants: 100
Study Start date:
November 27, 2024
Estimated Completion Date:
April 23, 2026

Connect with a study center

  • Ninewells Hospital & Medical School

    Dundee, DD1 9SY
    United Kingdom

    Active - Recruiting

  • Imperial College London

    London,
    United Kingdom

    Active - Recruiting

  • Manchester NHS Foundation Trust

    Manchester,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.